Company profile

HKPD

Cellyan Biotechnology Co., Ltd

NASDAQHealthcare

End-of-day prices provided by Twelve Data · One close per session. Not real time and not a quote.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

Declared intent to influence

Filed on Schedule 13D: the investor states an intention to influence how the company is run.

Liying Wang65.0%Oct 6, 25SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Passive holders

Filed on Schedule 13G: large stakes held without an intention to control — mostly index and institutional funds.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

46 filings on record, the oldest from Apr 26, 24.

Beta

Scores, historical analogues, watchlist and Radar work over the same companies you can already browse here.

Invite-only beta. Payments are not active yet.